Podcast
MSL Talk: Tom Caravela
All About Thought Leader Liaison
Summary
This weeks guest is Jim Hahn, Senior Business Director, Thought Leader Engagement at EMD Serono who discusses the role of the Thought Leader Liaison and how it fits into the pharma world.
Key Points
- Thought leader liaisons (TLLs) focus on building deep, strategic relationships with key opinion leaders (KOLs) to align commercial objectives with the needs of healthcare providers.
- TLLs typically come from successful sales backgrounds and do not require advanced scientific degrees, but must have strong interpersonal skills and a thorough understanding of their therapeutic area.
- Effective communication between TLLs, MSLs, and sales reps is crucial to ensure seamless interactions with healthcare professionals and to avoid conflicts over access and time.
This weeks guest is Jim Hahn, Senior Business Director, Thought Leader Engagement at EMD Serono who discusses the role of the Thought Leader Liaison and how it fits into the pharma world.
Thought Leader Engagement, Pharma Industry, Key Opinion Leaders, Strategic Relationships, Healthcare Professionals
Related Topics
You May Also Like
MSL Talk: Tom Caravela
Podcast
MSL Talk: Tom Caravela
How Should Medical Affairs Engage on Social Media
Article
S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
Article
Dylan V Neel, David S Shulman, Clement Ma, Florence Bourgeois, Steven G DuBois
Sponsorship of oncology clinical trials in the United States according to age of eligibility
Article
Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
Article
Karen Geary